Acute and chronic complications

Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine

Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine

People with autoimmune diabetes (AD) are at higher risk of death due to the development of its acute and long-term sequelae. The process towards a cure for AD should encompass the identification of new pathways to prevent beta-cell failure and complications. A deep knowledge of AD heterogeneity is essential to understand and tackle the processes leading to disease onset and progression.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma